Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing - 2Flu activity in US could continue to rise for weeks, top CDC epidemiologist says
- 3Find the Lively Food Markets of South America
- 4Fundamental Monetary Guidance for Going into Business
- 5Land Rover Just Unveiled Its Dakar Rally Defender
- Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- 7 Strange Apparatuses to Make Your Party Stick Out!
- Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value
- Worldwide Objections Ideal For A Golf Outing
- This Miraculous, Cliff-Perched Town In The South Of France Is A Sacred European Gem
- The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- Step by step instructions to Pick the Right Web-based Degree Program
- Mummified cheetahs found in Saudi caves shed light on lost populations
- Home Machine Basics: An Exhaustive Purchasing Guide
